Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a Better Quality of Life Over 600,000 Japanese patients suffer from ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, today announced the publication of long ...
REDWOOD CITY, California, December 10, 2018 - Pulmonx, a leader in interventional pulmonary device technology announced today that the National Institute for Health and Care Excellence (NICE) in the ...
Pulmonx, a leader in interventional pulmonary device technology announced today that the National Institute for Health and Care Excellence (NICE) in the UK has expanded its guidance on the diagnosis ...
Over 20,000 Patients Treated with the Non-Surgical Zephyr Valve for Severe Emphysema, a Form of COPD
The Zephyr Valve Helps COPD/Emphysema Patients Breathe Easier Without the Risk of Major Surgery 1 REDWOOD CITY, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- As part of COPD Awareness Month, Pulmonx ...
Jul. 1—MORGANTOWN — A new treatment for emphysema is coming to West Virginia. The Zephyr Valve, a treatment classified a medical breakthrough by the Food and Drug Administration, will be offered by ...
Positive Coverage Policy from Health Care Service Corporation (HCSC) Covers Blue Cross Blue Shield Members in Illinois, Montana, New Mexico, Oklahoma and Texas REDWOOD CITY, Calif., Nov. 02, 2020 ...
The FDA today approved the Zephyr endobronchial valve for treating breathing difficulty associated with severe emphysema, according to a press release. “Treatment options are limited for people with ...
>> HOW ARE YOU FEELING, HOW’S YOUR BREATHING? >> GOOD. EMILY: THAT’S A NEW EXPERIENCE FOR RICHARD WELLS. FOR 15 YEARS, HE HAS STRUGGLED TO BREATHE. >> I JUST COULDN’T DO ANYTHING. COULDN’T DO ANYTHING ...
A live and archived webcast of the event will be available on the “Investors” section of the Pulmonx website at About Pulmonx Corporation Pulmonx Corporation (Nasdaq: LUNG) is a global leader in ...
REDWOOD CITY, Calif. & TOKYO--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announced today that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback